This Nigerian startup wants your DNA to rewrite global medicine
- Syndicate Bio launched in September 2023 to enhance genomics and precision medicine in Africa.
- The company aims to address the lack of African genomic data, which hampers disease prevention and treatment.
- Direct by Syndicate Bio offers genetic testing services, including hereditary cancer tests and pharmacogenomics.
The establishment of Syndicate Bio and its Direct service represents a significant step towards addressing the healthcare challenges faced by African populations. By leveraging local genomic data, the initiative not only enhances patient care but also positions Africa as a critical player in global health research. Further discussions could explore the potential impacts of this innovation on healthcare policy and access across the continent.
